Mymetics Corp (MYMX)

[Work Harder]

Evercore ISI Group Upgrades Prothena Corp to Outperform, Announces $14 Price Target Benzinga_NewsdeskTue, 19 Nov 2019 06:53:40 -0500

Prothena Corp 13D Shows EcoR1 Capital Holds 23.6% Stake In Co.

Shares of several gene therapy companies are trading higher potentially in sympathy with Nightstar Therapeutics after the company announced it would be acquired by Biogen for $25.50 per share in cash.

Cantor Fitzgerald Assumes Prothena Corp at Overweight

4 Negative Enterprise Value Stocks

https://www.benzinga.com/stock/prta/?showOldTickerPage=1

Prothena Corporation plc Ordinary Shares (PRTA) Institutional Holdings

https://www.nasdaq.com/market-activity/stocks/prta/institutional-holdings